Should You Buy Aurora Cannabis (TSX:ACB) Stock at $5?

The meltdown in the share prices of Canada’s top marijuana stocks has investors wondering which cannabis stock might be the best pick right now for a contrarian investment. Let’s take a look and the current situation in the market and see if Aurora Cannabis (TSX:ACB)(NYSE:ACB) deserves to be on your contrarian buy list. Growing pains The marijuana industry is still…

Read More

KALY – Kali-Extracts To Review Acquisition Interest In Its Cannabis Extract Biopharmaceutical Technology This Wednesday, October 30, 2019

DALLAS, Oct. 28, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (KALY) (“KALY”) today announced plans to issue an update this Wednesday, October 30th, 2019 regarding the recent acquisition interest in KALY’s Cannabis Extract Biopharmaceutical Technology. KALY CEO Frederick Ferri commented on the acquisition interest in KALY’s Cannabis Extract Biopharmaceutical Technology indicating that…

Read More

TFSA Investors: This Cannabis Company Could Transform Your Portfolio

If you have a TFSA, high-growth stocks have a ton of appeal, as you’ll pay zero taxes on your gains. Even if your portfolio triples in value, your money will be shielded from the tax collector. There are few higher growth markets than cannabis. Most analysts agree that the market could surpass $100 billion in value by 2030. Stifel Financial…

Read More

3 High-Growth Stocks Set to Explode in 2020

It’s not difficult to find yesterday’s high-growth stocks. The problem arises when trying to find tomorrow’s high-growth stocks. Even worse, high-growth expectations are already baked into the price, meaning your upside will be limited. The trick is to find tomorrow’s high-growth stocks before everyone else. That way, your upside is maximized. When done right, this strategy can double or triple the…

Read More

3 Stocks to Buy for October

October is almost here, and there are three stocks that could be due for some big performances this coming month. Aphria (TSX:APHA)(NYSE:APHA) is expected to release its latest quarterly results in October. And if the stock can follow up with the positive results that it achieved back in July, we could see its share price get a big boost. Last…

Read More

3 Cannabis Stocks With the Fastest-Growing Sales

If you’re starting to get impatient with the cannabis industry, it might be time for a new method to the madness. After a stellar summer in 2018, things have slumped and then some for pot stocks. Only a few are trading even close to fair value, even though some have posted a profit. If you’re an investor looking to stick…

Read More

Cannabis Investing: The Safest Way to Gain Exposure Ahead of October

A few months ago, I wrote about the benefits of owning Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ) but that I wouldn’t recommend getting in at that price because the market seemed overvalued. Since then, the ETF has come down roughly 30%, leading many investors to wonder if now is a good time to buy the fund. The cannabis space…

Read More

3 Pot Stocks That Could Outsell Aurora Cannabis (TSX:ACB) in 2020

The last month has been incredibly interesting for cannabis investors, to say the least. While some pot producers out there were able to actually post a profit for once, others were still swamped with debt, with seemingly no end in sight. As the cannabis industry is still in its infancy, there are some coming out ahead in the short term,…

Read More

The Real Reason Pot Stocks Have Plunged

If the scandals and controversies in the marijuana industry aren’t enough, the shares of the two largest cannabis companies are plummeting. If the downtrend continues, will the entire industry collapse? In the last two months, Canopy (TSX:WEED)(NYSE:CGC) has fallen by 38%. Aurora (TSX:ACB)(NYSE:ACB) has dropped by 24%. The industry giants are losing steam, while investors’ interest is clearly fading. Ruptured…

Read More

Should You Buy Aphria (TSX:APHA) on the Dip?

August was looking like it would be a very good month for Aphria (TSX:APHA)(NYSE:APHA) after the stock soared on a good earnings report. However, since then, the stock has faltered, and it has dropped in value along with other cannabis stocks. On Monday, Aphria’s stock closed at $8.45 — a big fall from the high of more than $10 a share…

Read More